IFNG and Hepatic fibrosis: A previous study showed that LPS/IFN‐γ treated macrophages are more efficient for cytotherapy in experimental liver fibrosis.[9] However, these macrophages might produce a large amount of pro‐inflammatory cytokines in vivo, which have potential risks in clinical application.